Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
4370 results
Interventional
Not Applicable
50
Experimental
University of Health Sciences
Source: clinicaltrials.gov
Phase2
40
Total Neo-adjuvant Therapy
18FDG-PET/MRI scan
AHS Cancer Control Alberta
600
Cross-tailored Dynamic Feedback
Personalized Feedback Intervention
Dynamic Feedback on General Health Behaviors
Anne E Ray
30
Study drug: KN510 120mg/day + KN713 90mg/day, Combination Chemotherapy: mFOLFIRINOX
Study drug: KN510 120mg/day + KN713 120mg/day, Combination Chemotherapy: mFOLFIRINOX
New Cancer Cure-Bio Co.,Ltd.
Phase4
Anesthesia Maintenance Agent
Uppsala University
Observational
200
Spent media collection
Genomic Prediction Inc.
20
Floor Pedal Bike with Guided Instructions for Home
Wake Forest University Health Sciences
150
Percutaneous Patent Foramen Ovale Closure
No Intervention
First Affiliated Hospital Xi'an Jiaotong University
Phase1
90
Pulsed low dose rate radiotherapy (PLDR)
Alpaloritovorelli antibodies
Anhui Provincial Hospital
22
conventional osteotome technique
Hydrodynamic Piezoelectric technique
Hamid Abdul Rahman whispered